Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Igor Aurer

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2010English

Serum Chitotriosidase: A Circulating Biomarker in Polycythemia Vera

Hematology
Hematology
2018English

Related publications

Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop

British Journal of Haematology
Hematology
2016English

Prognostic Significance of Ki67 and Its Correlation With Mitotic Index in Dogs With Diffuse Large B-Cell Lymphoma Treated With 19-Week CHOP-based Protocol

Journal of Veterinary Diagnostic Investigation
Veterinary
2017English

Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma

British Journal of Haematology
Hematology
2017English

PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B-Cell LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB-CHOP (RCHOP) ± RADIOTHERAPY (RT)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Real-World Prognostic Impact of Bcl2 and Myc Expression and Translocation Among Diffuse Large B-Cell Lymphoma Patients Treated With First-Line R-Chop

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy

Tenri Medical Bulletin
2018English

MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy